TSPO Modulation in AD

by | Oct 1, 2025 | Clinical Trials | 0 comments

​ Conditions: Alzheimer s Disease

Interventions: Drug: XBD173

Sponsors: Imperial College London

Enrolling by invitation Conditions: Alzheimer s Disease
Interventions: Drug: XBD173
Sponsors: Imperial College London
Enrolling by invitation 

Submit a Comment

Your email address will not be published. Required fields are marked *